Cargando…

Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method

The World Health Organization (WHO) introduced “Coronavirus disease 19” or “COVID-19” as a novel coronavirus in March 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery of effective treatments to fight this worldwide crisis. Artificial intelligence and bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Taheri, Golnaz, Habibi, Mahnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384336/
https://www.ncbi.nlm.nih.gov/pubmed/35992221
http://dx.doi.org/10.1016/j.asoc.2022.109510
_version_ 1784769432452595712
author Taheri, Golnaz
Habibi, Mahnaz
author_facet Taheri, Golnaz
Habibi, Mahnaz
author_sort Taheri, Golnaz
collection PubMed
description The World Health Organization (WHO) introduced “Coronavirus disease 19” or “COVID-19” as a novel coronavirus in March 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery of effective treatments to fight this worldwide crisis. Artificial intelligence and bioinformatics analysis pipelines can assist with finding biomarkers, explanations, and cures. Artificial intelligence and machine learning methods provide powerful infrastructures for interpreting and understanding the available data. On the other hand, pathway enrichment analysis, as a dominant tool, could help researchers discover potential key targets present in biological pathways of host cells that are targeted by SARS-CoV-2. In this work, we propose a two-stage machine learning approach for pathway analysis. During the first stage, four informative gene sets that can represent important COVID-19 related pathways are selected. These “representative genes” are associated with the COVID-19 pathology. Then, two distinctive networks were constructed for COVID-19 related signaling and disease pathways. In the second stage, the pathways of each network are ranked with respect to some unsupervised scorning method based on our defined informative features. Finally, we present a comprehensive analysis of the top important pathways in both networks. Materials and implementations are available at: https://github.com/MahnazHabibi/Pathway.
format Online
Article
Text
id pubmed-9384336
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-93843362022-08-17 Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method Taheri, Golnaz Habibi, Mahnaz Appl Soft Comput Article The World Health Organization (WHO) introduced “Coronavirus disease 19” or “COVID-19” as a novel coronavirus in March 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery of effective treatments to fight this worldwide crisis. Artificial intelligence and bioinformatics analysis pipelines can assist with finding biomarkers, explanations, and cures. Artificial intelligence and machine learning methods provide powerful infrastructures for interpreting and understanding the available data. On the other hand, pathway enrichment analysis, as a dominant tool, could help researchers discover potential key targets present in biological pathways of host cells that are targeted by SARS-CoV-2. In this work, we propose a two-stage machine learning approach for pathway analysis. During the first stage, four informative gene sets that can represent important COVID-19 related pathways are selected. These “representative genes” are associated with the COVID-19 pathology. Then, two distinctive networks were constructed for COVID-19 related signaling and disease pathways. In the second stage, the pathways of each network are ranked with respect to some unsupervised scorning method based on our defined informative features. Finally, we present a comprehensive analysis of the top important pathways in both networks. Materials and implementations are available at: https://github.com/MahnazHabibi/Pathway. The Author(s). Published by Elsevier B.V. 2022-10 2022-08-17 /pmc/articles/PMC9384336/ /pubmed/35992221 http://dx.doi.org/10.1016/j.asoc.2022.109510 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Taheri, Golnaz
Habibi, Mahnaz
Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method
title Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method
title_full Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method
title_fullStr Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method
title_full_unstemmed Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method
title_short Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method
title_sort comprehensive analysis of pathways in coronavirus 2019 (covid-19) using an unsupervised machine learning method
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384336/
https://www.ncbi.nlm.nih.gov/pubmed/35992221
http://dx.doi.org/10.1016/j.asoc.2022.109510
work_keys_str_mv AT taherigolnaz comprehensiveanalysisofpathwaysincoronavirus2019covid19usinganunsupervisedmachinelearningmethod
AT habibimahnaz comprehensiveanalysisofpathwaysincoronavirus2019covid19usinganunsupervisedmachinelearningmethod